Julie A. Vetalice, Author at ORTHOWORLD

New ATTUNE Knee Implant Survivorship Data from DePuy Synthes

Independent analysis of 10,605 ATTUNE® Knee procedures showed a cumulative revision rate of 1.3% at 4 years vs. a 1.9% cumulative revision rate for the overall class of total knee replacement.

May 31, 2017

First Surgeries with Exactech’s Truliant Knee

Joint Replacement ORTHOFLASH

Exactech announced completion of initial Truliant® Knee procedures in its U.S. pilot launch.

May 31, 2017

Polyaxial ZIP ISP Technology Available for Out-Licensing

Company Updates Competitive Landscape

Aurora Spine’s proprietary implant locking technology is available for out-licensing or private labeling opportunities.

May 31, 2017

Hyalex Orthopaedics Raises $16 Million Series A Financing

Investments The Numbers

Hyalex Orthopaedics raised US $16MM in a Series A financing. The company is developing HYALEX™ synthetic polymer that is designed to mimic hyaline cartilage.

May 31, 2017

Ortho-ACI Approved on the Australian Register of Therapeutic Goods

Orthobiologics ORTHOFLASH

Orthocell received confirmation that Ortho-ACI® Autologous Chondrocyte Implantation is included on the Australian Register of Therapeutic Goods.

May 31, 2017

Zimmer Biomet Recalls Implantable Spinal Fusion Stimulators

ORTHOFLASH Spine

Zimmer Biomet is recalling SpF® PLUS-Mini and SpF XL IIb Implantable Spinal Fusion Stimulators due to potential cytotoxicity issues that were found during routine monitoring.

May 31, 2017